Obesity
Every post on obesity, newest first.
Posts
Studies5 min read
Retatrutide's 80-week trial shows weight loss and knee pain relief
In an 80-week trial, retatrutide led to weight loss up to 25% and reduced knee osteoarthritis pain more than placebo. A second diabetes trial used the same design.
Studies4 min read
A mouse study links KPV to slower fat cell formation
A 2026 cell and mouse study found that KPV reduced fat cell formation and eased signs of obesity on a high-fat diet. The work adds a metabolic angle to a peptide mostly studied for gut, skin, and mouth inflammation.
Compound pages
The evergreen research summaries these posts build on.
RetatrutideTriple-hormone agonist with substantial weight loss in trials.CagrilintideOnce-weekly investigational amylin analogue for weight management.DulaglutideOnce-weekly GLP-1 agonist for type 2 diabetes and heart-risk reduction.LiraglutideA once-daily GLP-1 injection approved for weight loss and diabetes.KPVAnti-inflammatory α-MSH tripeptide studied for gut and skin repair.BPC-157Gastric-derived peptide studied for tissue repair and cytoprotection.